Corteva annual diluted eps
Diluted EPSBasic EPS
2018
2019
2020
2021
2022
2023
2024
2025
Corteva EPS History: Annual & Quarterly (CTVA)
Corteva's diluted EPS was $1.60 for fiscal 2025.
View full Corteva company overviewCorteva annual diluted eps history
| Fiscal year | Period ended | Diluted EPS | Basic EPS | Change | Growth |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.60 | $1.60 | $0.30 | +23.08% |
| 2024 | 2024-12-31 | $1.30 | $1.31 | $0.27 | +26.21% |
| 2023 | 2023-12-31 | $1.03 | $1.04 | -$0.55 | −34.81% |
| 2022 | 2022-12-31 | $1.58 | $1.59 | -$0.79 | −33.33% |
| 2021 | 2021-12-31 | $2.37 | $2.39 | $1.46 | +160.44% |
| 2020 | 2020-12-31 | $0.91 | $0.91 | $2.19 | — |
| 2019 | 2019-12-31 | -$1.28 | -$1.28 | $5.48 | — |
| 2018 | 2018-12-31 | -$6.76 | -$6.76 | — | — |
Corteva quarterly diluted eps
Diluted EPSBasic EPS
Q2.18
Q3.18
Q1.19
Q2.19
Q3.19
Q1.20
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Diluted EPS | Basic EPS | Change | YoY change |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.73 | $1.73 | -$0.19 | −9.90% |
| Q1 2026 | 2026-03-31 | $1.07 | $1.07 | $0.12 | +12.63% |
| Q4 2025 | 2025-12-31 | -$0.82 | -$0.82 | — | — |
| Q3 2025 | 2025-09-30 | -$0.47 | -$0.47 | $0.29 | — |
| Q2 2025 | 2025-06-30 | $1.92 | $1.92 | $0.41 | +27.15% |
| Q1 2025 | 2025-03-31 | $0.95 | $0.95 | $0.35 | +58.33% |
| Q3 2024 | 2024-09-30 | -$0.76 | -$0.76 | -$0.31 | — |
| Q2 2024 | 2024-06-30 | $1.51 | $1.51 | $0.51 | +51.00% |
| Q1 2024 | 2024-03-31 | $0.60 | $0.60 | -$0.23 | −27.71% |
| Q3 2023 | 2023-09-30 | -$0.45 | -$0.45 | $0.01 | — |
| Q2 2023 | 2023-06-30 | $1.00 | $1.00 | -$0.33 | −24.81% |
| Q1 2023 | 2023-03-31 | $0.83 | $0.84 | $0.05 | +6.41% |
| Q3 2022 | 2022-09-30 | -$0.46 | -$0.46 | -$0.50 | — |
| Q2 2022 | 2022-06-30 | $1.33 | $1.34 | $0.02 | +1.53% |
| Q1 2022 | 2022-03-31 | $0.78 | $0.78 | -$0.02 | −2.50% |
| Q3 2021 | 2021-09-30 | $0.04 | $0.04 | $0.56 | — |
| Q2 2021 | 2021-06-30 | $1.31 | $1.31 | $0.30 | +29.70% |
| Q1 2021 | 2021-03-31 | $0.80 | $0.81 | $0.44 | +122.22% |
| Q3 2020 | 2020-09-30 | -$0.52 | -$0.52 | $0.14 | — |
| Q2 2020 | 2020-06-30 | $1.01 | $1.01 | $1.82 | — |
| Q1 2020 | 2020-03-31 | $0.36 | $0.36 | $0.14 | +63.64% |
| Q3 2019 | 2019-09-30 | -$0.66 | -$0.66 | $6.17 | — |
| Q2 2019 | 2019-06-30 | -$0.81 | -$0.81 | -$1.73 | — |
| Q1 2019 | 2019-03-31 | $0.22 | $0.22 | — | — |
| Q3 2018 | 2018-09-30 | -$6.83 | -$6.83 | — | — |
| Q2 2018 | 2018-06-30 | $0.92 | $0.92 | — | — |
Corteva diluted eps trends
Over the last five fiscal years, Corteva's diluted eps increased from $0.91 to $1.60, a change of $0.69. The latest reported quarter, Q2 2026, shows $1.73.
About the metric
What earnings per share (EPS) means
Earnings per share (EPS) shows how much profit or loss is attributable to each common share. Diluted EPS includes the potential effect of convertible securities, options, and other instruments that could increase the share count, while basic EPS uses the weighted-average common shares actually outstanding.
Calculation and source
SEC-reported diluted and basic EPS
TickerStat displays diluted and basic earnings per share from SEC filings. Historical EPS values are adjusted to the current share basis when SEC-reported stock-split conversion ratios are available; they are not analyst estimates or earnings forecasts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Corteva source filings ↗Community posts
Corteva settles Inari seed-IP case, with licensing talks still pending
Corteva ($CTVA) and Inari have reached a confidential settlement of Corteva’s seed-related intellectual-property lawsuit in Delaware. Inari agreed to destroy Corteva material accessed through seed depositories, together with material develo ...
Corteva clears SEC registration milestone for Vylor separation
Corteva ($CTVA) said the SEC declared Vylor’s Form 10 registration statement effective, advancing the planned separation of its seed and genetics business. Eligible Corteva shareholders are scheduled to receive one Vylor share for each Cort ...
Chemours, DuPont and Corteva agree to a $455 million PFAS settlement
Chemours ($CC), DuPont ($DD) and Corteva ($CTVA) reached an agreement to resolve PFAS-related claims brought by North Carolina and 11 local government entities. The settlement provides for $455 million in nominal payments over 15 years. Che ...
